The citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance
International Journal of Risk & Safety in Medicine (2016) - Comment
pubmed: 27176755  doi: 10.3233/jrs-160671  issn: 1878-6847  issn: 0924-6479 

Jon N. Jureidini, Jay D. Amsterdam, Leemon B. McHenry